Advancing a sustainable healthcare society through expertise cultivated for over 70 years for peace of mind of people and the future of healthcare.
We provide reliable insights by integrating a secure data platform with advanced technologies, including AI, and consulting services.
CRECON Health Intelligence
CRECON Group is a team of experts dedicated to providing reliable information and solutions to the healthcare and pharmaceutical industries,contributing to the realization of a sustainable healthcare society.
-
Crecon Genomics Inc.
-
CRECON Medical Assessment Inc.
-
CRECON Research &
Consulting Inc. -
Encise Inc
-
MEDICODE Inc
Encise Inc. and MEDICODE Inc. are joint venture partners.
ABOUT US
What is CRECON Group
High-quality healthcare is delivered to everybody whenever needed. At CRECON Group, we provide the support to realize such society and ensure peace of mind.
For example, we provide specialized expertise needed for the challenges of new drug development and play the role of supporting the infrastructure to ensure stable pharmaceutical supply.
While we often work behind the scenes, we take great pride in our contributions to healthcare in Japan. We are committed to making steady progress toward a future where everyone can access medical care with peace of mind.
NEWS
Latest News
-
All
-
-
-
-
-
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (May2026)'published.
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (April2026)'published.
-
Japan Ethical Drug Sales 'ANNUAL Snapshot (04/2025 to 03/2026)'published.
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (March2026)'published.
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (February2026)'published.
-
Hitoshi Kimura, President and CEO served as the guest speaker for a Special Lecture at the 58th Tokai Pharmaceutical Conference (December 7, 2025), hosted by the Aichi Pharmaceutical Association.(The 58th Tokai Pharmaceutical Conference, Special Lecture: “Issues and Outlook for Japan’s Pharmaceutical Supply from an International Perspective”)
-
Hitoshi Kimura, President and CEO, served as a guest speaker for an educational lecture at the Joint Academic Congress of Three Societies (October 18-19, 2025). The congress was held by the Japanese Society of Oral Therapeutics and Pharmacology, the Japan Dental Society of Oriental Medicine, and the Japanese Association for Oral Infectious Diseases.(October 19, 2025, Educational Lecture 2 at the Joint Academic Congress of Three Societies: “Fundamental Causes of Pharmaceutical Supply Shortages and the Challenge of Ensuring Stable Supply in Japan”)
-
An article of a guest lecture by Hitoshi Kimura, President and CEO, was published in the September issue of the Journal of Japan Pharmaceutical Wholesalers Association (2025 Vol.49 No.9).(July 17th, 2025, Lecture session at “HILL TOP SEMINAR 2025”: “Changes in the Pharmaceutical Distribution Environment and the Potential of Pharma Wholesalers”)
-
A comment on the stable supply of pharmaceuticals by Chikako Koike, Head of the Healthcare Research Center, was published in Nihon Keizai Shimbun (morning edition, dated April 7, 2025).（“...
-
An article of Hitoshi Kimura, President and CEO, was published in YAKUJI NIPPO on March 10th, 2025. (Overview of trends surrounding pharmaceutical wholesalers)
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (May2026)'published.
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (April2026)'published.
-
Japan Ethical Drug Sales 'ANNUAL Snapshot (04/2025 to 03/2026)'published.
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (March2026)'published.
-
Japan Ethical Drug Sales 'Encise Monthly Snapshot (February2026)'published.
No announcements at this time.
CRECON Research & Consulting Inc.
It is committed to realizing a society where essential medical care is appropriately delivered to those in need. We address healthcare challenges in Japan by providing insights derived from our extensive research into domestic and overseas healthcare systems and related industries.
CRECON Medical Assessment Inc.
By aligning the price of pharmaceuticals and medical technologies with their true value, we contribute to achieving a sustainable society where high-quality healthcare is accessible to all.
Crecon Genomics Inc.
It contributes to optimization of treatment selection and development of effective preventive measures by performing advanced analysis of genomic data based on the latest research findings from Japan and abroad.
Encise Inc.
In collaboration with pharmaceutical wholesalers nationwide, it utilizes demand data on where and how many pharmaceuticals are needed to ensure the efficient and appropriate use of limited healthcare resources.